These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34666740)

  • 41. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
    Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021.
    Tran TN; Wikle NB; Yang F; Inam H; Leighow S; Gentilesco B; Chan P; Albert E; Strong ER; Pritchard JR; Hanage WP; Hanks EM; Crawford FW; Boni MF
    JAMA Netw Open; 2022 May; 5(5):e2214171. PubMed ID: 35616938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response to COVID-19 in Cyprus: Policy changes and epidemic trends.
    Kakoullis L; Eliades E; Papachristodoulou E; Parperis K; Chra P; Constantinidou A; Chatzittofis A; Sampsonas F; Panos G
    Int J Clin Pract; 2021 Apr; 75(4):e13944. PubMed ID: 33338320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modeling Effects of Spatial Heterogeneities and Layered Exposure Interventions on the Spread of COVID-19 across New Jersey.
    Ren X; Weisel CP; Georgopoulos PG
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nowcasting and Forecasting the Spread of COVID-19 and Healthcare Demand in Turkey, a Modeling Study.
    Arslan S; Ozdemir MY; Ucar A
    Front Public Health; 2020; 8():575145. PubMed ID: 33553085
    [No Abstract]   [Full Text] [Related]  

  • 47. India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.
    Mandal S; Arinaminpathy N; Bhargava B; Panda S
    BMJ Open; 2021 Jul; 11(7):e048874. PubMed ID: 34215611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study.
    Davies NG; Kucharski AJ; Eggo RM; Gimma A; Edmunds WJ;
    Lancet Public Health; 2020 Jul; 5(7):e375-e385. PubMed ID: 32502389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada.
    Tuite AR; Fisman DN; Greer AL
    CMAJ; 2020 May; 192(19):E497-E505. PubMed ID: 32269018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A modelling analysis of the effectiveness of second wave COVID-19 response strategies in Australia.
    Milne GJ; Xie S; Poklepovich D; O'Halloran D; Yap M; Whyatt D
    Sci Rep; 2021 Jun; 11(1):11958. PubMed ID: 34099788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India.
    Pons-Salort M; John J; Watson OJ; Brazeau NF; Verity R; Kang G; Grassly NC
    Emerg Infect Dis; 2022 Apr; 28(4):759-766. PubMed ID: 35213800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chopping the tail: How preventing superspreading can help to maintain COVID-19 control.
    Kain MP; Childs ML; Becker AD; Mordecai EA
    Epidemics; 2021 Mar; 34():100430. PubMed ID: 33360871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review.
    Regmi K; Lwin CM
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 transmission and control in a hospital setting: an individual-based modelling study.
    Huang Q; Mondal A; Jiang X; Horn MA; Fan F; Fu P; Wang X; Zhao H; Ndeffo-Mbah M; Gurarie D
    R Soc Open Sci; 2021 Mar; 8(3):201895. PubMed ID: 33959348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India.
    Purkayastha S; Kundu R; Bhaduri R; Barker D; Kleinsasser M; Ray D; Mukherjee B
    BMC Res Notes; 2021 Jul; 14(1):262. PubMed ID: 34238344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study.
    Panovska-Griffiths J; Kerr CC; Stuart RM; Mistry D; Klein DJ; Viner RM; Bonell C
    Lancet Child Adolesc Health; 2020 Nov; 4(11):817-827. PubMed ID: 32758453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the impacts of non-pharmaceutical interventions on the transmission dynamics of COVID-19 in Canada based on mobile network.
    Xue L; Jing S; Wang H
    PLoS One; 2021; 16(12):e0261424. PubMed ID: 34965272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M
    PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamics of the COVID-19 epidemic in Ireland under mitigation.
    Cazelles B; Nguyen-Van-Yen B; Champagne C; Comiskey C
    BMC Infect Dis; 2021 Aug; 21(1):735. PubMed ID: 34344318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.